| scholarly article | Q13442814 |
| P356 | DOI | 10.1086/502416 |
| P698 | PubMed publication ID | 15188849 |
| P50 | author | Marin H Kollef | Q76082664 |
| P2093 | author name string | Linda M Mundy | |
| Laura A Puzniak | |||
| Terry Leet | |||
| Kathleen N Gillespie | |||
| P2860 | cites work | APACHE II: a severity of disease classification system | Q29547729 |
| A hospital epidemic of vancomycin-resistant Enterococcus: risk factors and control | Q30307268 | ||
| Cost-effectiveness of perirectal surveillance cultures for controlling vancomycin-resistant Enterococcus | Q30309847 | ||
| Hospital stay and mortality attributed to nosocomial enterococcal bacteremia: a controlled study | Q30459629 | ||
| Vancomycin-resistant enterococci: the clinical effect of a common nosocomial pathogen. | Q33544736 | ||
| Reporting of vancomycin-resistant enterococci in Connecticut: implementation and validation of a state-based surveillance system | Q33756679 | ||
| Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group | Q33852247 | ||
| Impact of antibiotic resistance on clinical outcomes and the cost of care | Q34212049 | ||
| Impact of gowning on visit length and physical examinations | Q34752021 | ||
| Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit | Q35821697 | ||
| Health and economic outcomes of vancomycin-resistant enterococci | Q38487139 | ||
| A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit | Q39428847 | ||
| Yield of vancomycin-resistant enterococci and multidrug-resistant Enterobacteriaceae from stools submitted for Clostridium difficile testing compared to results from a focused surveillance program | Q39463844 | ||
| Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people | Q40880211 | ||
| The effectiveness of cost-effectiveness analysis in containing costs | Q41448945 | ||
| Clostridium difficile infection is a risk factor for bacteremia due to vancomycin-resistant enterococci (VRE) in VRE-colonized patients with acute leukemia | Q41663859 | ||
| A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis | Q42289230 | ||
| Laboratory-based surveillance for vancomycin-resistant enterococci: utility of screening stool specimens submitted for Clostridium difficile toxin assay | Q43580408 | ||
| A comparison of multifaceted versus Clostridium difficile-focused VRE surveillance strategies in a low-prevalence setting | Q43622228 | ||
| Cost of hospitalization for and risk factors associated with vancomycin-resistant Enterococcus faecium infection and colonization | Q43681129 | ||
| Should Canada and the United States universally vaccinate infants against hepatitis B? A cost-effectiveness analysis | Q44020464 | ||
| To gown or not to gown: the effect on acquisition of vancomycin-resistant enterococci | Q44024979 | ||
| Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci. | Q44200926 | ||
| Safety of patients isolated for infection control | Q44610067 | ||
| Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations | Q45788736 | ||
| Cost-effectiveness of a routine varicella vaccination program for US children | Q46364346 | ||
| The cost of hospital-acquired infection and the value of infection control. | Q52864002 | ||
| Measuring the costs of nosocomial infections: Methods for estimating economic burden on the hospital | Q57274713 | ||
| Cost and benefit in control of nosocomial infection: methods for analysis | Q71598137 | ||
| Gowning does not affect colonization or infection rates in a neonatal intensive care unit | Q72704343 | ||
| The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable | Q74598543 | ||
| Evaluating the cost-effectiveness of clinical and public health measures | Q74610210 | ||
| Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: is it cost effective? | Q78082915 | ||
| P433 | issue | 5 | |
| P921 | main subject | vancomycin | Q424027 |
| cost–benefit analysis | Q942582 | ||
| P304 | page(s) | 418-424 | |
| P577 | publication date | 2004-05-01 | |
| P1433 | published in | Infection Control and Hospital Epidemiology | Q6029185 |
| P1476 | title | A cost-benefit analysis of gown use in controlling vancomycin-resistant Enterococcus transmission: is it worth the price? | |
| P478 | volume | 25 |
| Q46448797 | A computer simulation model of the cost-effectiveness of routine Staphylococcus aureus screening and decolonization among lung and heart-lung transplant recipients |
| Q35975135 | An Economic Analysis of Strategies to Control Clostridium Difficile Transmission and Infection Using an Agent-Based Simulation Model |
| Q44539645 | Clostridium difficile in the intensive care unit: epidemiology, costs, and colonization pressure |
| Q43462048 | Contamination, acquisition, and transmission of pathogens: implications for research and practice of infection control |
| Q41739024 | Cost savings of universal decolonization to prevent intensive care unit infection: implications of the REDUCE MRSA trial |
| Q35846925 | Cost-benefit analysis from the hospital perspective of universal active screening followed by contact precautions for methicillin-resistant Staphylococcus aureus carriers |
| Q38000023 | Cost-effectiveness analysis of active surveillance screening for methicillin-resistant Staphylococcus aureus in an academic hospital setting. |
| Q42951270 | Cost-effectiveness of adding decolonization to a surveillance strategy of screening and isolation for methicillin-resistant Staphylococcus aureus carriers |
| Q35739134 | Economic value of Acinetobacter baumannii screening in the intensive care unit |
| Q43173943 | Outbreak of influenza A (2009) H1N1 among Thai healthcare workers: is it time to integrate a vaccination program? |
| Q28315870 | Outbreak of varicella-zoster virus infection among Thai healthcare workers |
| Q43175489 | Outbreaks of influenza A among nonvaccinated healthcare workers: implications for resource-limited settings |
| Q57256931 | Pre-emptive contact precautions for intubated patients reduced healthcare-associated meticillin-resistant Staphylococcus aureus transmission and infection in an intensive care unit |
| Q45419001 | Prevalence of and risk factors for colonization with vancomycin-resistant enterococcus among human immunodeficiency virus-positive outpatients |
| Q37177819 | Prevention of hospital-acquired infections: review of non-pharmacological interventions |
| Q43173717 | Reduction of Seasonal Influenza Transmission among Healthcare Workers in an Intensive Care Unit: A 4-Year Intervention Study in Thailand |
| Q41201892 | The cost-benefit of federal investment in preventing Clostridium difficile infections through the use of a multifaceted infection control and antimicrobial stewardship program. |
| Q36333071 | The economic burden of patient safety targets in acute care: a systematic review |
| Q36582287 | The potential economic value of screening hospital admissions for Clostridium difficile |
| Q80064095 | [Recommendation for the prevention of nosocomial infections in neonatal intensive care patients with a birth weight less than 1,500 g. Report by the Committee of Hospital Hygiene and Infection Prevention of the Robert Koch Institute] |
Search more.